Cargando…

Non-Invasive Evaluation of Acute Effects of Tubulin Binding Agents: A Review of Imaging Vascular Disruption in Tumors †

Tumor vasculature proliferates rapidly, generally lacks pericyte coverage, and is uniquely fragile making it an attractive therapeutic target. A subset of small-molecule tubulin binding agents cause disaggregation of the endothelial cytoskeleton leading to enhanced vascular permeability generating i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Li, O’Kelly, Devin, Schuetze, Regan, Carlson, Graham, Zhou, Heling, Trawick, Mary Lynn, Pinney, Kevin G., Mason, Ralph P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8125421/ https://www.ncbi.nlm.nih.gov/pubmed/33925707 http://dx.doi.org/10.3390/molecules26092551

Ejemplares similares

Demonstrating Tumor Vascular Disrupting Activity of the Small-Molecule Dihydronaphthalene Tubulin-Binding Agent OXi6196 as a Potential Therapeutic for Cancer Treatment
por: Liu, Li, et al.
Publicado: (2022)

Imaging-Guided Evaluation of the Novel Small-Molecule Benzosuberene Tubulin-Binding Agent KGP265 as a Potential Therapeutic Agent for Cancer Treatment
por: Guo, Yihang, et al.
Publicado: (2021)

Tomographic breathing detection: a method to noninvasively assess in situ respiratory dynamics
por: O’Kelly, Devin, et al.
Publicado: (2018)

Tubulin-Destabilizing Agent BPR0L075 Induces Vascular-Disruption in Human Breast Cancer Mammary Fat Pad Xenografts
por: Liu, Li, et al.
Publicado: (2012)

Cevipabulin-tubulin complex reveals a novel agent binding site on α-tubulin with tubulin degradation effect
por: Yang, Jianhong, et al.
Publicado: (2021)

Evaluating online filtering algorithms to enhance dynamic multispectral optoacoustic tomography
por: O’Kelly, Devin, et al.
Publicado: (2020)

Current Advances of Tubulin Inhibitors in Nanoparticle Drug Delivery and Vascular Disruption/Angiogenesis
por: Banerjee, Souvik, et al.
Publicado: (2016)

The vascular disrupting agent combretastatin A-4 phosphate causes prolonged elevation of proteins involved in heme flux and function in resistant tumor cells
por: Dey, Sanchareeka, et al.
Publicado: (2017)

Integrating mechanisms of response and resistance against the tubulin binding agent Eribulin in preclinical models of osteosarcoma
por: Sampson, Valerie B., et al.
Publicado: (2016)

Comparison of Optical and Power Doppler Ultrasound Imaging for Non-Invasive Evaluation of Arsenic Trioxide as a Vascular Disrupting Agent in Tumors
por: Alhasan, Mustafa K., et al.
Publicado: (2012)

Tubulin and Tubulin Posttranslational Modifications in Alzheimer’s Disease and Vascular Dementia
por: Santiago-Mujika, Estibaliz, et al.
Publicado: (2021)

Chlamydomonas reinhardtii tubulin-gene disruptants for efficient isolation of strains bearing tubulin mutations
por: Kato-Minoura, Takako, et al.
Publicado: (2020)

Slug increases sensitivity to tubulin-binding agents via the downregulation of βIII and βIVa-tubulin in lung cancer cells
por: Tamura, Daisuke, et al.
Publicado: (2013)

Effects of tubulin acetylation and tubulin acetyltransferase binding on microtubule structure
por: Howes, Stuart C., et al.
Publicado: (2014)

Evaluation of Antivascular and Antimitotic Effects of Tubulin Binding Agents in Solid Tumor Therapy
por: Nihei, Yukio, et al.
Publicado: (1999)

Quinolin-6-Yloxyacetamides Are Microtubule Destabilizing Agents That Bind to the Colchicine Site of Tubulin
por: Sharma, Ashwani, et al.
Publicado: (2017)

Vascular disrupting agents in clinical development
por: Hinnen, P, et al.
Publicado: (2007)

Interaction of the novel agent amphethinile with tubulin.
por: McGown, A. T., et al.
Publicado: (1989)

Vascular disrupting agent induced aggregation of gold nanoparticles for photothermally enhanced tumor vascular disruption
por: Hong, Sheng, et al.
Publicado: (2020)

Taxol binds to polymerized tubulin in vitro
por: Parness, J, et al.
Publicado: (1981)

Comprehensive Analysis of Binding Sites in Tubulin
por: Mühlethaler, Tobias, et al.
Publicado: (2021)

Tubulin-interactive stilbene derivatives as anticancer agents
por: Mikstacka, Renata, et al.
Publicado: (2013)

Tubulin tyrosination regulates synaptic function and is disrupted in Alzheimer’s disease
por: Peris, Leticia, et al.
Publicado: (2022)

Tubulin tyrosine ligase structure reveals adaptation of an ancient fold to bind and modify tubulin
por: Szyk, Agnieszka, et al.
Publicado: (2011)

A cryptic tubulin-binding domain links MEKK1 to curved tubulin protomers
por: Filipčík, Pavel, et al.
Publicado: (2020)

Spatio-temporal distribution of tubulin-binding cofactors and posttranslational modifications of tubulin in the cochlea of mice
por: Juergens, Lukas, et al.
Publicado: (2020)

Design, Synthesis, and Biological Evaluation of Stable Colchicine Binding Site Tubulin Inhibitors as Potential Anticancer Agents
por: Lu, Yan, et al.
Publicado: (2014)

Plocabulin, a novel tubulin-binding agent, inhibits angiogenesis by modulation of microtubule dynamics in endothelial cells
por: Galmarini, Carlos M., et al.
Publicado: (2018)

Preclinical and Early Clinical Development of PTC596, a Novel Small-Molecule Tubulin-Binding Agent
por: Jernigan, Finith, et al.
Publicado: (2021)

C1, a highly potent novel curcumin derivative, binds to tubulin, disrupts microtubule network and induces apoptosis
por: Srivastava, Shalini, et al.
Publicado: (2016)

The architecture of Trypanosoma brucei tubulin-binding cofactor B and implications for function
por: Fleming, Jennifer R, et al.
Publicado: (2013)

PPARγ Inhibitors as Novel Tubulin-Targeting Agents
por: Schaefer, Katherine L.
Publicado: (2008)

Computational Approaches to the Rational Design of Tubulin-Targeting Agents
por: Pérez-Peña, Helena, et al.
Publicado: (2023)

Differential Disruption of EWS-FLI1 Binding by DNA-Binding Agents
por: Chen, Changmin, et al.
Publicado: (2013)

Plinabulin, an inhibitor of tubulin polymerization, targets KRAS signaling through disruption of endosomal recycling
por: Cimino, Patrick J., et al.
Publicado: (2019)

Vascular Disrupting Agent Drug Classes Differ in Effects on the Cytoskeleton
por: Kim, Sujeong, et al.
Publicado: (2012)

Tumor resistance to vascular disrupting agents: mechanisms, imaging, and solutions
por: Liang, Wenjie, et al.
Publicado: (2016)

An audit of community-acquired pneumonia antimicrobial compliance using an intervention bundle in an Irish hospital
por: O’Kelly, Brendan, et al.
Publicado: (2020)

[5]-Helistatins: Tubulin-Binding Helicenes with Antimitotic Activity
por: Rushworth, James L., et al.
Publicado: (2022)

Tubulin Isotypes and Posttranslational Modifications in Vascular Dementia and Alzheimer’s Disease
por: Santiago-Mujika, Estibaliz, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_f7u2h3eo8459iqs53n2id8537e